Happy to announce our paper on FAIRification is now live ! A true testament to what patient-driven collaboration can achieve. Read here: https://t.co/AskgzrKjOR
Applications are now open for the 2026 edition of the Open Academy Schools, offering intensive, face-to-face training in Barcelona from 25-28 May 2026.
Don’t miss the chance to be part of this unique opportunity! – APPLY NOW!
https://t.co/owya6x8sH7
We’re proud to announce that DDF is now ISO/IEC 27001:2022 certified!
This milestone reflects our commitment to protecting the community’s trust and ensuring secure, responsible use of data to accelerate research and care.
#DuchenneCommunity#ISO27001#RareDisease
🎓 The #EURORDIS Open Academy Alumni Mentoring Programme is here!
Designed to help trained advocates grow, connect & lead through peer support and expert mentorship.
🔗 Learn more: https://t.co/aQltdL12g4
#RareDisease#PatientAdvocacy #OpenAcademy#DDF
🚨 Registration open! Join the free FAIR Training Programme on health & rare disease data 🧬 24–26 Sept 2025, 13:30–17:00 CET, online. Learn to make data Findable, Accessible, Interoperable & Reusable!
Register: https://t.co/q1As3nQ56w
#FAIRdata #RareDisease#DDF
The role of patient advocacy groups in the EU research projects' design and implementation is crucial, especially when is concerning management of research data! https://t.co/xM6VSZiw9r #MAGICProject#Dystrophinopathy#DataScience#GeneticTherapies
🚀 Join us for the ERDERA launch event!
🗓️ 28 Oct 2024
⏰ 14:00-16:15 CET
💻 Online
Don't miss insights from top experts & learn how @ERDERA_org is set to change the landscape of rare diseases research!
👉 RSVP here:https://t.co/Xb3trTuebd
#RareDiseases@EU_HaDEA
🌐 Are you attending the 29th Annual Congress of World Muscle Society?
Visit our virtual poster!For the first time ever the World Muscle Society has a poster section entirely dedicated to dystrophin and the brain!
📣 Apply Now for the 2025 Open Academy Trainings!
Applications are now open for the 2025 edition of the Open Academy Schools, offering intensive, face-to-face training in Barcelona from 2-5 June 2025.
See more information here
https://t.co/lpgJGoFMLg
You are invited to join the BIND Patient Community webinar 'Understanding the role of dystrophin in the brain'
🗓 Monday, September 23
🕕 18:00 CEST
📍 Online via Zoom
👉 Please register your interest here: https://t.co/WmO55sycui
Looking forward to joining forces with LUMC to improve our understanding of the cognitive profile in people living with DMD and BMD.
https://t.co/k9tHEdPscB
Thrilled to announce that @LUMC_Leiden and @DuchenneDF have secured funding to further continue deep phenotyping of the brain in Duchenne and Becker muscular dystrophy.
🤝 This will further enhance the understanding of brain involvement in DMD and BMD.
https://t.co/ro6k1S1Nv6
@EU_BIND@LUMC_Leiden Looking forward to collaborating with LUMC on this project to improve our understanding of the cognitive profile in people living with DMD and BMD.
📢 We are thrilled to announce our participation in the ERDERA patnership launched just last week! 🚀
Read ERDERA’s press release to learn more
https://t.co/2q96MR1rhY
#ERDERA#RareDiseases#ResearchInnovation
🌟 Exciting News on a new MOOC (Massive Open Online Course) titled “Innovative Therapies and Personalized Medicine for Rare Diseases” 🌟
The MOOC will start on Monday July 8th, and enrollments is now open at: https://t.co/H1eLFCab5g
🌟 Exciting News on a new MOOC (Massive Open Online Course) titled “Innovative Therapies and Personalized Medicine for Rare Diseases” 🌟
The MOOC will start on Monday July 8th, and enrollments is now open at: https://t.co/H1eLFCaIUO
Prof. Francesco Saverio Tedesco from the MAGIC project presented the innovative approaches and significant implications of the MAGIC Project at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Baltimore, USA (May 7-11 2024).
https://t.co/fkcS0X9JYj